Items where authors include "Marshall, H"
Up a levelArticle
Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736
Coen, O, Corrie, P, Marshall, H et al. (17 more authors) (2021) The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma. BMC Cancer, 21. 761. ISSN 1471-2407
Hall, PS, Swinson, D, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (32 more authors) (2021) Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical Trial. JAMA oncology, 7 (6). pp. 869-877. ISSN 2374-2437
Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736
Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736
Harji, DP, Marshall, H, Gordon, K orcid.org/0000-0003-1483-0657 et al. (11 more authors) (2020) Laparoscopic versus open colorectal surgery in the acute setting (LaCeS trial): a multicentre randomized feasibility trial. British Journal of Surgery, 107 (12). pp. 1595-1604. ISSN 0007-1323
Seligmann, JF, Wright-Hughes, A orcid.org/0000-0001-8839-6756, Pottinger, A et al. (10 more authors) (2020) Lapatinib plus Capecitabine versus Trastuzumab plus Capecitabine in the Treatment of Human Epidermal Growth Factor Receptor 2-positive Metastatic Breast Cancer with Central Nervous System Metastases for Patients Currently or Previously Treated with Trastuzumab (LANTERN): a Phase II Randomised Trial. Clinical Oncology, 32 (10). pp. 656-664. ISSN 0936-6555
Walsh, JS, Marshall, H orcid.org/0000-0003-0944-0152, Smith, IL et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277
Danson, S, Hook, J, Marshall, H orcid.org/0000-0003-0944-0152 et al. (4 more authors) (2019) Are we over-treating with checkpoint inhibitors? British Journal of Cancer, 121 (8). pp. 629-630. ISSN 0007-0920
Westbrook, JA, Wood, SL, Cairns, DA orcid.org/0000-0002-2338-0179 et al. (14 more authors) (2019) Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer. The Journal of pathology, 247 (3). pp. 381-391. ISSN 0022-3417
Coleman, RE, Collinson, M orcid.org/0000-0003-3568-6455, Gregory, W orcid.org/0000-0003-2641-8416 et al. (20 more authors) (2018) Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). Journal of Bone Oncology, 13. pp. 123-135. ISSN 2212-1374
Corrigan, N, Marshall, H, Croft, J orcid.org/0000-0001-7586-3394 et al. (3 more authors) (2018) Exploring and adjusting for potential learning effects in ROLARR: a randomised controlled trial comparing robotic-assisted vs. standard laparoscopic surgery for rectal cancer resection. Trials, 19 (1). 339. ISSN 1745-6215
Wilson, C, Bell, R, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (5 more authors) (2018) Adjuvant zoledronic acid reduces fractures in breast cancer patients; an AZURE (BIG 01/04) study. European Journal of Cancer, 94. pp. 70-78. ISSN 0959-8049
Harji, D, Marshall, H, Gordon, K et al. (10 more authors) (2018) Feasibility of a multicentre, randomised controlled trial of laparoscopic versus open colorectal surgery in the acute setting: the LaCeS feasibility trial protocol. BMJ Open, 8 (2). e018618. ISSN 2044-6055
Brown, J, Rathbone, E, Hinsley, S orcid.org/0000-0001-6903-4688 et al. (13 more authors) (2018) Associations Between Serum Bone Biomarkers in Early Breast Cancer and Development of Bone Metastasis: Results From the AZURE (BIG01/04) Trial. Journal of the National Cancer Institute, 110 (8). pp. 871-879. ISSN 0027-8874
Coleman, R, Hall, A, Albanell, J et al. (10 more authors) (2017) Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial. The Lancet Oncology, 18 (11). pp. 1543-1552. ISSN 1470-2045
Wilson, C, Hinsley, S orcid.org/0000-0001-6903-4688, Marshall, H et al. (4 more authors) (2017) Reproductive hormone analyses and effects of adjuvant zoledronic acid in early breast cancer – an AZURE (BIG 01/04) sub-study. Journal of Bone Oncology, 9. pp. 48-54. ISSN 2212-1374
Jayne, D orcid.org/0000-0002-8725-3283, Pigazzi, A, Marshall, H orcid.org/0000-0003-0944-0152 et al. (13 more authors) (2017) Effect of Robotic-Assisted vs Conventional Laparoscopic Surgery on Risk of Conversion to Open Laparotomy Among Patients Undergoing Resection for Rectal Cancer: The ROLARR Randomized Clinical Trial. Journal of the American Medical Association, 318 (16). pp. 1569-1580. ISSN 0098-7484
Abbosh, C, Birkbak, NJ, Wilson, GA et al. (425 more authors) (2017) Phylogenetic ctDNA analysis depicts early stage lung cancer evolution. Nature, 545. pp. 446-451. ISSN 0028-0836
Hall, PS, Lord, SR, Collinson, M et al. (12 more authors) (2017) A randomised phase II trial and feasibility study of palliative chemotherapy in frail or elderly patients with advanced gastroesophageal cancer (321GO). British Journal of Cancer, 116. pp. 472-478. ISSN 0007-0920
Westbrook, JA, Cairns, DA orcid.org/0000-0002-2338-0179, Peng, J et al. (10 more authors) (2016) CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment. JNCI: Journal of the National Cancer Institute, 108 (4). ISSN 0027-8874
Coleman, R, Cameron, D, Dodwell, D et al. (13 more authors) (2014) Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial. The Lancet Oncology, 15 (9). 997 - 1006. ISSN 1470-2045
Middleton, G, Brown, S, Lowe, C et al. (17 more authors) (2013) A randomised phase III trial of the pharmacokinetic biomodulation of irinotecan using oral ciclosporin in advanced colorectal cancer: results of the Panitumumab, Irinotecan & Ciclosporin in COLOrectal cancer therapy trial (PICCOLO). European Journal of Cancer, 49 (16). 3507 - 3516. ISSN 0959-8049
Coleman, R, Hinsley, S orcid.org/0000-0001-6903-4688, Bell, R et al. (7 more authors) (2013) Adjuvant therapy in early breast cancer with zoledronic acid (AZURE - BIG 01/04): Final efficacy analysis. European Journal of Cancer, 49 (Suppl 3). S5-S5. ISSN 0959-8049
Coleman, RE, Gregory, W, Marshall, H et al. (2 more authors) (2013) The metastatic microenvironment of breast cancer: clinical implications. Breast, 22 S2. S50 - S56. ISSN 0960-9776
Seymour, MT, Brown, SR, Middleton, G et al. (18 more authors) (2013) Panitumumab and irinotecan versus irinotecan alone for patients with KRAS wild-type, fluorouracil-resistant advanced colorectal cancer (PICCOLO): a prospectively stratified randomised trial. The Lancet Oncology, 14 (8). 749 - 759. ISSN 1470-2045
Collinson, FJ, Jayne, DG, Pigazzi, A et al. (13 more authors) (2012) An international, multicentre, prospective, randomised, controlled, unblinded, parallel-group trial of robotic-assisted versus standard laparoscopic surgery for the curative treatment of rectal cancer. International Journal of Colorectal Disease, 27 (2). 233 - 241. ISSN 0179-1958
Coleman, RE, Marshall, H, Bell, R et al. (1 more author) (2012) Breast-cancer adjuvant therapy with zoledronic acid REPLY. New England Journal of Medicine, 366 (2). 189 - 189. ISSN 0028-4793
Coleman, RE, Marshall, H, Cameron, D et al. (7 more authors) (2011) Breast-cancer adjuvant therapy with zoledronic acid. The New England Journal of Medicine, 365 (15). 1396 - 1405. ISSN 0028-4793
Conference or Workshop Item
Hall, P, Swinson, D, Lord, S et al. (23 more authors) (2019) Optimizing Chemotherapy for Frail and Elderly Patients with Advanced Gastroesophageal Cancer (aGOAC): the GO2 Phase III Trial. In: 2019 NCRI Cancer Conference of National Cancer Research Institute, 03-05 Nov 2019, Glasgow, Scotland, UK.
Hall, P, Swinson, D, Lord, S et al. (7 more authors) (2019) Chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): Quality of Life (QoL) results from the GO2 phase III trial. In: 44th ESMO Congress (ESMO 2019), 27 Sep - 01 Oct 2019, Barcelona, Spain.
Swain, J, Smith, I, Smith, A et al. (3 more authors) (2015) TRYMS: The ethical and practical considerations of a double-blind placebo controlled randomised clinical trial. In: 3rd International Clinical Trials Methodology Conference, 16-17 Nov 2015, Glasgow, UK. (Unpublished)
Proceedings Paper
Swinson, D, Hingorani, M, Stokes, Z et al. (15 more authors) (2019) Best supportive care (BSC) with or without low-dose chemotherapy (chemo) in frail elderly patients with advanced gastroesophageal cancer (aGOAC): The uncertain randomization of the GO2 phase III trial. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, USA. American Society of Clinical Oncology , p. 4051.
Hall, PS, Swinson, D, Waters, JS et al. (17 more authors) (2019) Optimizing chemotherapy for frail and elderly patients (pts) with advanced gastroesophageal cancer (aGOAC): The GO2 phase III trial. In: Journal of Clinical Oncology. Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), 31 May - 04 Jun 2019, Chicago, USA. American Society of Clinical Oncology .
West, NP orcid.org/0000-0002-0346-6709, Jayne, DG orcid.org/0000-0002-8725-3283, Pigazzi, A et al. (11 more authors) (2016) Short Term Pathology Results from the First World Wide Randomised Trial of Robotic Versus Laparoscopic Resection for Rectal Cancer (ROLARR). In: Journal of Pathology. Nottingham Pathology 2016. 9th Joint Meeting of the British Division of the International Academy of Pathology and the Pathological Society of Great Britain & Ireland, 28 Jun - 01 Jul 2016, Nottingham, UK. Wiley , S17-S17.